Bliden KP - Search Results

1

The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response.

Lewis JP, Horenstein RB, Ryan K, O'Connell JR, Gibson Q, Mitchell BD, Tanner K, Chai S, Bliden KP, Tantry US, Peer CJ, Figg WD, Spencer SD, Pacanowski MA, Gurbel PA, Shuldiner AR. Lewis JP, et al. Among authors: bliden kp. Pharmacogenet Genomics. 2013 Jan;23(1):1-8. doi: 10.1097/FPC.0b013e32835aa8a2. Pharmacogenet Genomics. 2013. PMID: 23111421 Free PMC article.

2

Durability of platelet inhibition by clopidogrel.

Gurbel PA, Bliden KP. Gurbel PA, et al. Among authors: bliden kp. Am J Cardiol. 2003 May 1;91(9):1123-5. doi: 10.1016/s0002-9149(03)00163-2. Am J Cardiol. 2003. PMID: 12714161 Clinical Trial. No abstract available.

3

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.

Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Gurbel PA, et al. Among authors: bliden kp. Circulation. 2003 Jun 17;107(23):2908-13. doi: 10.1161/01.CIR.0000072771.11429.83. Epub 2003 Jun 9. Circulation. 2003. PMID: 12796140 Clinical Trial.

4

Interpretation of platelet inhibition by clopidogrel and the effect of non-responders.

Gurbel PA, Bliden KP. Gurbel PA, et al. Among authors: bliden kp. J Thromb Haemost. 2003 Jun;1(6):1318-9. doi: 10.1046/j.1538-7836.2003.t01-3-00326.x. J Thromb Haemost. 2003. PMID: 12871339 Free article. No abstract available.

5

The early antiplatelet effects of clopidogrel loading for coronary stenting and the long-term stability of inhibition.

Gurbel PA, Bliden KP, Hiatt BL. Gurbel PA, et al. Among authors: bliden kp. J Thromb Haemost. 2003 Jun;1(6):1319-21. doi: 10.1046/j.1538-7836.2003.00184.x. J Thromb Haemost. 2003. PMID: 12871340 Free article. Clinical Trial. No abstract available.

6

Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy).

Gurbel PA, Galbut B, Bliden KP, Bahr RD, Roe MT, Serebruany VL, Gibler WB, Christenson RH, Ohman EM; EARLY Platelet Substudy. Gurbel PA, et al. Among authors: bliden kp. J Thromb Thrombolysis. 2002 Dec;14(3):213-9. doi: 10.1023/a:1025048726396. J Thromb Thrombolysis. 2002. PMID: 12913401 Clinical Trial.

7

Platelet activation after stenting with heparin-coated versus noncoated stents.

Gurbel PA, Bliden KP. Gurbel PA, et al. Among authors: bliden kp. Am Heart J. 2003 Oct;146(4):E10. doi: 10.1016/S0002-8703(03)00317-X. Am Heart J. 2003. PMID: 14564333 Clinical Trial.

8

A new method of representing drug-induced platelet inhibition: better description of time course, response variability, non-response, and heightened activity.

Gurbel PA, Bliden KP. Gurbel PA, et al. Among authors: bliden kp. Platelets. 2003 Nov-Dec;14(7-8):481-3. doi: 10.1080/02697450310001632588. Platelets. 2003. PMID: 14713517 No abstract available.

9

The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapy.

Gurbel PA, Bliden KP. Gurbel PA, et al. Among authors: bliden kp. Thromb Res. 2003;112(1-2):9-12. doi: 10.1016/j.thromres.2003.09.029. Thromb Res. 2003. PMID: 15013266 Clinical Trial.

10

Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosis.

Gurbel PA, Samara WM, Bliden KP. Gurbel PA, et al. Among authors: bliden kp. Platelets. 2004 Mar;15(2):95-9. doi: 10.1080/09537100310001646950. Platelets. 2004. PMID: 15154601 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page